Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Buprenorphine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buprenorphine 16mg/0.32ml prolonged-release inj pfs
0410030A0AAAPAP
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 8 |
|
Buprenorphine 8mg/0.16ml prolonged-release inj pfs
0410030A0AAANAN
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 6 |
|
Buprenorphine 32mg/0.64ml prolonged-release inj pfs
0410030A0AAARAR
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 3 |
|
Buprenorphine 1mg sublingual tablets sugar free
0410030A0AAAIAI
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 4mg sublingual tablets sugar free
0410030A0AAAKAK
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 6mg sublingual tablets sugar free
0410030A0AAAJAJ
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 74.2mg implant
0410030A0AAAWAW
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 0.4mg sublingual tablets
0410030A0BEAFAC
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 1mg sublingual tablets
0410030A0BEACAI
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 2mg sublingual tablets
0410030A0BEAAAD
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 4mg sublingual tablets
0410030A0BEAEAK
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 6mg sublingual tablets
0410030A0BEADAJ
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 8mg sublingual tablets
0410030A0BEABAE
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Natzon 0.4mg sublingual tablets
0410030A0BDACAC
|
Natzon | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Natzon 2mg sublingual tablets
0410030A0BDAAAD
|
Natzon | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Natzon 8mg sublingual tablets
0410030A0BDABAE
|
Natzon | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Sixmo 74.2mg implant
0410030A0BHAAAW
|
Sixmo | Buprenorphine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.